Inflammation and immunology disease models become informative when induction, pathway biology, and endpoints represent relevant aspects of human disease biology. We then connect in-life disease
Immunological disease-model platforms are most valuable when pathology, immune phenotyping, and longitudinal assessment must be interpreted together. We connect those readouts through documented methods, controls, and
Developers of therapies for autoimmune hematologic diseases need models that connect the therapy with the relevant immune compartment, disease mechanism, and translational readout. We evaluate that
October 10, 2026
No Comments
Newsletter
Sign up our newsletter to get update information, news and free insight.